Holen Sie sich die Stockscreener-App
1.76
10.00%
0.16
Handel nachbörslich:
1.78
0.02
+1.14%
Schlusskurs vom Vortag:
$1.60
Offen:
$1.65
24-Stunden-Volumen:
4.01M
Relative Volume:
1.31
Marktkapitalisierung:
$34.59M
Einnahmen:
$2.05M
Nettoeinkommen (Verlust:
$-23.15M
KGV:
-0.2654
EPS:
-6.6319
Netto-Cashflow:
$-16.93M
1W Leistung:
+37.50%
1M Leistung:
+104.77%
6M Leistung:
+74.26%
1J Leistung:
-34.08%
1-Tages-Spanne:
$1.61
$1.81
1-Wochen-Bereich:
$1.24
$1.81
52-Wochen-Spanne:
$0.5562
$6.8908
iBio Inc Stock (IBIO) Company Profile
Firmenname
iBio Inc
Sektor
Branche
Telefon
302-355-0650
Adresse
600 Madison Avenue, Suite 1601, New York, NY
Vergleichen Sie IBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IBIO
iBio Inc
|
1.76 | 32.41M | 2.05M | -23.15M | -16.93M | -6.6319 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
iBio Inc Stock (IBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-21 | Eingeleitet | Oppenheimer | Outperform |
| 2025-10-17 | Eingeleitet | Leerink Partners | Outperform |
| 2024-05-28 | Eingeleitet | Chardan Capital Markets | Buy |
| 2021-11-29 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-01-22 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2020-06-26 | Eingeleitet | Alliance Global Partners | Buy |
Alle ansehen
iBio Inc Aktie (IBIO) Neueste Nachrichten
Key metrics from iBio Inc.’s quarterly dataJuly 2025 Decliners & Verified Short-Term Plans - newser.com
Using AI based signals to follow iBio Inc.Market Performance Report & Daily Stock Momentum Reports - newser.com
Can trapped investors hope for a rebound in iBio Inc.Swing Trade & Daily Price Action Insights - newser.com
What to expect from iBio Inc. in the next 30 days2025 Macro Impact & Weekly Chart Analysis and Guides - newser.com
Why iBio Inc. stock appeals to dividend seekersDip Buying & Stock Portfolio Risk Management - newser.com
How iBio Inc. (0JV0) stock responds to job market shiftsJuly 2025 Closing Moves & Fast Gain Stock Trading Tips - newser.com
Why iBio Inc. stock is rated strong buy2025 Breakouts & Breakdowns & Community Shared Stock Ideas - newser.com
Why analysts raise outlook for iBio Inc. (0JV0) stockProduct Launch & Verified Momentum Stock Alerts - newser.com
Why iBio Inc. (0JV0) stock trades below fair valueTrade Exit Report & Free AI Powered Buy and Sell Recommendations - newser.com
What high frequency data says about iBio Inc.Weekly Profit Analysis & AI Powered Market Entry Strategies - newser.com
Is iBio Inc. stock attractive for long term wealth buildingQuarterly Profit Review & Safe Entry Trade Reports - newser.com
Does iBio Inc. (0JV0) stock trade below intrinsic valueTrend Reversal & Low Risk Entry Point Guides - newser.com
Why iBio Inc. (0JV0) stock could be next leader2025 Market Trends & Scalable Portfolio Growth Methods - newser.com
How iBio Inc. (0JV0) stock compares with market leadersEarnings Recap Summary & Smart Money Movement Alerts - newser.com
Analyzing iBio Inc. with multi timeframe chartsJuly 2025 Macro Moves & Weekly High Return Opportunities - newser.com
iBio Inc. stock retracement – recovery analysis2025 Market Sentiment & Breakout Confirmation Trade Signals - newser.com
Using flow based indicators on iBio Inc.2025 Earnings Impact & Free Long-Term Investment Growth Plans - newser.com
Risk vs reward if holding onto iBio Inc.Portfolio Return Report & Entry and Exit Point Strategies - newser.com
iBio Inc (0JV0.BE) stock price, news, quote and history - Yahoo! Finance UK
Wave, Ibio activin E action in obesity early but solid - BioWorld MedTech
Roth MKM Sticks to Its Buy Rating for Ibio (IBIO) - The Globe and Mail
iBio Unveils Promising Preclinical Data for IBIO-610 - The Globe and Mail
Real time pattern detection on iBio Inc. stockWeekly Risk Report & Entry Point Confirmation Signals - newser.com
How buybacks impact iBio Inc. stock valueEarnings Risk Report & Stepwise Trade Execution Plans - newser.com
Oppenheimer Maintains IBio Inc(IBIO.US) With Buy Rating, Raises Target Price to $6 - 富途牛牛
Finanzdaten der iBio Inc-Aktie (IBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.64%
0.35%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):